Mitral valve prolapse, or MVP, is a condition in which the valve between the heart’s left upper chamber and the left lower chamber does not close properly. The flaps of the mitral valve bulge into the left atrium every time the heart contracts, keeping the valve from closing tightly. If blood leaks backward through the valve, it is called mitral valve regurgitation. If only a small amount leaks, it likely will not cause problems, but if it is severe, it may require treatment. Listening to it through a stethoscope, MVP often produces a clicking sound as the valve’s flaps billow out, followed by a murmur as blood flows back into the chamber. Treatment depends on the severity of the symptoms.
Mitral valve (MV) repair is a treatment for mitral valve disease, including for a leaking (regurgitant) mitral valve and a narrowed (stenotic) mitral valve. The MV is located between two chambers of the heart, the left atrium and the left ventricle. This valve ensures that blood flow keeps going in the proper direction. Surgery may be needed when the valve is hardened (calcified), blocking blood from moving through it, or is too loose, causing blood to flow backward (regurgitate). Repair rather than replacement of the MV is now the usual method of treating MV disease, largely because MV repair avoids the need for most blood thinning medication, and has better long-term survival. The repair is usually performed with minimally invasive methods: a doctor can operate on the heart valve through a two- to three-inch incision near the breastbone or through some smaller cuts in the chest that allow the use of a tiny camera and special surgical tools (endoscopic surgery). Open surgery with advanced techniques may be required in more complex cases. A heart-lung machine may be used while the valve is repaired. A patient may expect to spend three to five days in the hospital after surgery, including up to two days in an intensive care unit.
The UAB Structural Heart & Valve Program is the oldest and largest program of its kind in Alabama. It provides ongoing care – sometimes for life – to patients who have or are at risk for structural heart and valve disease. Our experienced surgeons and cardiologists take a comprehensive approach to diagnosing and treating this condition, and their expertise ranges from traditional open-heart surgery to robotic-assisted valve repair and the latest in minimally invasive surgical techniques, which require only small incisions (cuts).
The UAB Structural Heart & Valve Clinic has achieved several important milestones in the past decade. In 2012, we performed the first transcatheter aortic valve replacement (TAVR) in Alabama, and UAB has performed more TAVR procedures than any other hospital in the state. As an added service, patients who have been told by non-UAB doctors that they need valve surgery can speak to a UAB structural heart and valve surgeon for a second opinion.
- James Davies, MD | Aortic Valve ReplacementDr. James Davies appeared on ABC 33/40’s “Talk of Alabama” to discuss UAB’s expertise in aortic valve replacement.WatchClose
- Heart Valve DiseaseThe heart has four valves that are responsible for keeping blood moving through its chambers and around the body. James Davies, MD, a cardiothoracic surgeon at UAB, talks to Daytime Alabama on WVTM-TV, Channel 13, in Birmingham, Ala., about how valve disease can be prevented, detected, and treated.WatchClose
- Sarah’s HeartWhen Sarah Ford found out she needed heart surgery, she made the drive from her home in Dothan to Birmingham to receive treatment at UAB. The experienced surgeons, compassionate staff, and cutting-edge care at UAB made her feel secure and safe.WatchClose
- Meet the Team: Kyle Eudailey, MDDr. Eudailey specializes in adult cardiac surgery, including aortic surgery and transcatheter treatment of valve disease. He is grateful for the opportunity to help patients improve their quality of life.WatchClose
Find a Provider to Schedule an Appointment
Are you a Physician or Provider?
24-Hour Consultation Referral Services
Speak to your physician about your options and browse the link below for more information
Featured HighlightsView All News
November 21, 2023
Latest NewsView All News
UAB researchers demonstrate how genetics play a role in the development of hypertension
October 27, 2023
UAB researchers first to define normal natriuretic peptide level range across lifespan of healthy US population
October 9, 2023
Study shows B-type natriuretic peptides lose prognostic value for clinical outcomes in LVAD recipients with cardiogenic shock
September 18, 2023
New kidney function equation may reduce health disparities by improving access to heart failure therapy in previously ineligible patients
August 7, 2023
UAB HHT Clinic named Center of Excellence
July 11, 2023